Lexeo Therapeutics, Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LXEO research report →
About the company
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates.
- CEO
- R. Nolan Townsend
- IPO
- 2023
- Employees
- 75
- HQ
- New York City, US
Price Chart
- Market Cap
- $368.27M
- P/E
- -3.23
- P/S
- 0.00
- P/B
- 1.64
- EV/EBITDA
- -3.57
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -47.48%
- ROIC
- -40.94%
- Revenue
- $0 · 0.00%
- Net Income
- $-99,961,000 · -1.66%
- EPS
- $-1.86 · 39.81%
- Op Income
- $-109,257,000
- FCF YoY
- -21.22%
- 52W High
- $10.99
- 52W Low
- $3.60
- 50D MA
- $5.12
- 200D MA
- $7.13
- Beta
- 1.39
- Avg Volume
- 895.97K
Get TickerSpark's AI analysis on LXEO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | Tamayo Louis Edward | other | 12,000 |
| Jul 1, 26 | Tamayo Louis Edward | sell | 4,641 |
| Jun 29, 26 | Otero Jose Manuel | other | 12,060 |
| Jul 1, 26 | Otero Jose Manuel | sell | 4,666 |
| Jun 29, 26 | Bhalla Narinder Pal | other | 55,000 |
| Jul 1, 26 | Bhalla Narinder Pal | sell | 22,306 |
| Jun 29, 26 | Townsend Richard Nolan | other | 67,000 |
| Jul 1, 26 | Townsend Richard Nolan | sell | 25,947 |
| Jun 25, 26 | Altschuler Steven | other | 35,000 |
| Jun 25, 26 | Agger Mette Kirstine | other | 35,000 |
Our LXEO coverage
Recent articles, reports, and earnings notes.
No research on LXEO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LXEO report →Similar companies
Peers in the same neighborhood.